ABBVIE INC. vs. Ardelyx, Inc.
ABBVIE INC. (ABBV) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| ABBV | ARDX | |
|---|---|---|
| Market Cap | $434.78 billion | $996.75 million |
| Revenue (TTM) | $64.39 billion | $450.89 million |
| Net Income (TTM) | $6.32 billion | $-55,702,000 |
ABBV leads on 3 of 3 size & scale factors.
Valuation
| ABBV | ARDX | |
|---|---|---|
| P/E Ratio | 69.50 | — |
| Price / Book | -73.84 | 6.69 |
| Price / Sales | 6.75 | 2.21 |
ABBV and ARDX split the valuation factors evenly.
Profitability
| ABBV | ARDX | |
|---|---|---|
| Net Margin | 9.81% | -12.35% |
| Return on Equity | -107.29% | -37.38% |
ABBV and ARDX split the profitability factors evenly.
Dividend
| ABBV | ARDX | |
|---|---|---|
| Dividend Yield | 2.81% | — |
| Payout Ratio | 195.48 | — |
ABBV and ARDX split the dividend factors evenly.
Risk & Sentiment
| ABBV | ARDX | |
|---|---|---|
| Short Interest | 0.85% | 0.76% |
ARDX leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, ARDX overview, ARDX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.